Advancements in Reprogramming iPSC-Derived Stem Cell Therapy to Replace & Restore Degenerated RPE Cells in Late-Stage AMD

Time: 1:30 pm
day: Conference Day Two


  • Exploring the latest advancements in using iPSCs to generate RPE cells for cell replacement therapy in late-stage AMD
  • Discussing the process of reprogramming iPSCs into functional RPE cells and the challenges associated with ensuring their proper integration and functionality within the retina
  • Presenting preclinical and clinical evidence supporting the safety and efficacy of iPSC-derived cell therapy in restoring retinal function and preserving vision in patients with advanced AMD